• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Canopy Growth Powers European Expansion with UK Entry

SMITHS FALLS – Canopy Growth Corp. announced that it will supply four Canadian-grown medical Cannabis flower strains for distribution in the United Kingdom, expanding its international Cannabis business into another European market. The products will ...

Public Opinion Fires Up Support for Cannabis in NC

RALEIGH – A large majority of North Carolina adults support legalizing adult-use Cannabis for medical use, and a smaller but clear majority backs recreational legalization as well, according to an Elon University Poll. The survey ...

Public Opinion Fires Up Support for Cannabis in NC

RALEIGH – A large majority of North Carolina adults support legalizing adult-use Cannabis for medical use, and a smaller but clear majority backs recreational legalization as well, according to an Elon University Poll. The survey ...

SNDL Reports Q2 2026 Financial and Operational Results

EDMONTON – SNDL Inc. announced the completion of assets acquisition from Surterra Holdings, Inc. and its affiliates, collectively known as Parallel, a vertically integrated Cannabis operator with state-licensed operations in Florida, Texas, and Massachusetts. The ...

Jushi Reports Q2 2026 Financial Results

BOCA RATON – Jushi Holdings Inc. released its second-quarter 2026 financial results, posting revenue of $71.3 million, a 10% year-over-year gain, with growth spread across both the retail and wholesale channels. The wholesale segment set ...

Vireo Growth Sets Stage for Planet 13 Acquisition

MINNEAPOLIS - LAS VEGAS – Vireo Growth Inc. and Planet 13 Holdings Inc. have agreed to combine operations under a definitive merger agreement. The move brings together two multi-state Cannabis operators and expands retail reach ...

Q2 2026: The Quarter That Counted For Psychedelics

LOS ANGELES – Q2 2026 gave the psychedelic medicine sector the quarter that practitioners, investors, and regulators had been building up for years. Clinical programs delivered Phase 3 results, the White House signed an executive ...

Subscribe To Our Newsletter

Go to Top